Tranexamic Acid: Clinical Trials

10 trials of Tranexamic Acid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 terminated. 10 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 310Terminated 10
Phase 21Terminated 1

Follow Tranexamic Acid: new trials by email Literature Review of Tranexamic Acid trials Research Report on Tranexamic Acid

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure
Tranexamic Acid, 0.9% sodium chloride - Cancer of the Bone, Limb Salvage
Phase 3TerminatedSt. Jude Children's Research Hospital152021-01-292024-12-20
DEPOSITION - Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery
Tranexamic Acid - Bleeding, Surgical Blood Loss
Phase 3TerminatedPopulation Health Research Institute32422019-09-172026-10-26
Minimize Menorrhagia in Women With Von Willebrand Disease
recombinant von Willebrand factor, tranexamic acid - Von Willebrand Diseases
Phase 3TerminatedMargaret Ragni392019-02-072024-07-01
Efficacy and Safety of Tranexamic Acid in Spinal Fusion Surgery
Sodium Chloride 0.9% Inj, Tranexamic Acid - Spinal Fusion
Phase 3TerminatedExela Pharma Sciences, LLC.52018-10-172021-06-21
Tocilizumab (RoActemra) and Tranexamic Acid (Cyklokapron) Used as Adjuncts to Chronic Subdural Hematoma Surgery
Tranexamic acid and Tocilizumab - Chronic Subdural Hematoma
Phase 2 / Phase 3TerminatedOslo University Hospital3822017-11-282021-10-13
Preoperative Hexakapron Reduces Bleeding in Bariatric Surgery
tranexamic acid, Placebo - Intra-Operative Injury - Other, Post Operative Hemorrhage
Phase 3TerminatedSheba Medical Center1522017-09-012023-04-19
HiFIT Study : Hip Fracture: Iron and Tranexamic Acid
Iron Isomaltoside 1000, Tranexamic Acid, Placebos iron isomaltoside 1000 - Hip Fractures Pathologic, Anemia
Phase 3TerminatedUniversity Hospital, Angers4192017-03-312022-08-02
Topical Application of Tranexamic Acid and Postoperative Blood Loss in Femoral Neck Fractures
Tranexamic Acid, placebo - Femoral Neck Fracture
Phase 3TerminatedDr. Jeff Yach152013-04-012018-11-30
Postoperative Bleeding Prevention in Massive Bone Tumour Resection
Tranexamic Acid, Fibrin glue, Electrocauterization - Blood Loss, Bone Tumour
Phase 3TerminatedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau562013-03-012016-09-20
Tranexamic Acid Versus Placebo to Reduce Perioperative Bleeding After Major Hepatectomy
acid tranexamic, Nacl 0.9% - Blood Loss, Surgical
Phase 3TerminatedUniversity Hospital, Strasbourg, France1302008-08-202021-03-01

Conditions studied

Blood Loss, Surgical (2)  ·  Bone Neoplasms (2)  ·  Hemorrhage (2)  ·  Anemia (1)  ·  Femoral Neck Fractures (1)  ·  Fractures, Bone (1)  ·  Hematoma, Subdural, Chronic (1)  ·  Menorrhagia (1)  ·  Obesity, Morbid (1)  ·  Postoperative Hemorrhage (1)  ·  Seizures (1)  ·  von Willebrand Diseases (1)

Sponsors

Dr. Jeff Yach (1)  ·  Exela Pharma Sciences, LLC. (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  Margaret Ragni (1)  ·  Oslo University Hospital (1)  ·  Population Health Research Institute (1)  ·  Sheba Medical Center (1)  ·  St. Jude Children's Research Hospital (1)  ·  University Hospital, Angers (1)  ·  University Hospital, Strasbourg, France (1)

Countries

United States (3)  ·  Canada (2)  ·  France (2)  ·  China (1)  ·  Czechia (1)  ·  Israel (1)  ·  Malaysia (1)  ·  New Zealand (1)  ·  Norway (1)  ·  Russia (1)  ·  Spain (1)

Top investigators

Andre Lamy, MD (1)  ·  Jeff Yach, MD (1)  ·  Margaret V Ragni, MD, MPH (1)  ·  Michael D. Neel, MD (1)  ·  Milo Stanisic (1)  ·  Neel Anand, MD (1)  ·  Patrick Pessaux (1)  ·  Sigismond SL Lasocki, PU-PH (1)

Results publications

PMID 18480196, PMID 22054656, PMID 27774838, PMID 30146969, PMID 30908754, PMID 33455926, PMID 33781988, PMID 37385272, PMID 37524101, PMID 38587333, PMID 38689774, PMID 42423601

NIH funding

2017 (1), U01HL133815 (1)